+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Hereditary Angioedema Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Hereditary Angioedema Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Microscopic Polyangiitis Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Microscopic Polyangiitis Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
From
Von Hippel-Lindau Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Von Hippel-Lindau Disease Epidemiology Forecast 2025-2034

  • Report
  • March 2026
  • 150 Pages
  • Global
From
Chronic Otitis Media (COM) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Chronic Otitis Media (COM) Epidemiology Forecast 2025-2034

  • Report
  • March 2026
  • 150 Pages
  • Global
From
Erythropoietic Protoporphyria Pipeline Analysis Report 2025 - Product Thumbnail Image

Erythropoietic Protoporphyria Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
Allergy Rhinitis Drugs Market 2026-2030 - Product Thumbnail Image

Allergy Rhinitis Drugs Market 2026-2030

  • Report
  • August 2026
  • 296 Pages
  • Global
From
Pd-1 and Pd-L1 Inhibitors Market 2026-2030 - Product Thumbnail Image

Pd-1 and Pd-L1 Inhibitors Market 2026-2030

  • Report
  • April 2026
  • 286 Pages
  • Global
From
Global Hyaluronic Acid Raw Material Market 2026-2030 - Product Thumbnail Image

Global Hyaluronic Acid Raw Material Market 2026-2030

  • Report
  • October 2026
  • 306 Pages
  • Global
From
Global Anti-Inflammatory Therapeutics Market 2026-2030 - Product Thumbnail Image

Global Anti-Inflammatory Therapeutics Market 2026-2030

  • Report
  • September 2026
  • 299 Pages
  • Global
From
Global Allergy Immunotherapies Market 2026-2030 - Product Thumbnail Image

Global Allergy Immunotherapies Market 2026-2030

  • Report
  • September 2026
  • 290 Pages
  • Global
From
Global Anti-Cd20 Monoclonal Antibodies (Mabs) Market 2026-2030 - Product Thumbnail Image

Global Anti-Cd20 Monoclonal Antibodies (Mabs) Market 2026-2030

  • Report
  • September 2026
  • 342 Pages
  • Global
From
Global Glucosamine Market 2026-2030 - Product Thumbnail Image

Global Glucosamine Market 2026-2030

  • Report
  • September 2026
  • 297 Pages
  • Global
From
Global Atopic Dermatitis Drugs Market 2026-2030 - Product Thumbnail Image

Global Atopic Dermatitis Drugs Market 2026-2030

  • Report
  • September 2026
  • 299 Pages
  • Global
From
Global Autoimmune Hemolytic Anemia Therapeutics Market 2026-2030 - Product Thumbnail Image

Global Autoimmune Hemolytic Anemia Therapeutics Market 2026-2030

  • Report
  • September 2026
  • 292 Pages
  • Global
From
Autoimmune Drugs Market 2026-2030 - Product Thumbnail Image

Autoimmune Drugs Market 2026-2030

  • Report
  • August 2026
  • 337 Pages
  • Global
From
Human Immunoglobulin Market 2026-2030 - Product Thumbnail Image

Human Immunoglobulin Market 2026-2030

  • Report
  • August 2026
  • 309 Pages
  • Global
From
Hyaluronic Acid Market 2026-2030 - Product Thumbnail Image

Hyaluronic Acid Market 2026-2030

  • Report
  • August 2026
  • 307 Pages
  • Global
From
Antibody Market 2026-2030 - Product Thumbnail Image

Antibody Market 2026-2030

  • Report
  • May 2026
  • 304 Pages
  • Global
From
Heart Transplantation Therapeutics Market 2026-2030 - Product Thumbnail Image

Heart Transplantation Therapeutics Market 2026-2030

  • Report
  • May 2026
  • 333 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more